• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液凝固的新观念。

Newer concepts of blood coagulation.

作者信息

Roberts H R, Monroe D M, Oliver J A, Chang J Y, Hoffman M

机构信息

Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, USA.

出版信息

Haemophilia. 1998 Jul;4(4):331-4. doi: 10.1046/j.1365-2516.1998.440331.x.

DOI:10.1046/j.1365-2516.1998.440331.x
PMID:9873750
Abstract

In this report we describe an in vitro model of blood coagulation reactions that mimics as closely as possible the in vivo condition. Our model indicates that the tissue factor-factor VIIa complex initiates coagulation by activating small amounts of both factor IX and factor X in the environment of the tissue factor bearing cell. Factor Xa and factor IXa formed in the initial reaction then play very distinct roles in the subsequent interactions of the clotting mechanism leading to a burst of thrombin generation on the platelet surface. Our results also indicate that factor XI can be activated by thrombin in the absence of factor XII and that the function of factor XI is simply to enhance conversion of factor IX to factor IXa resulting in enhanced thrombin generation on the platelet surface.

摘要

在本报告中,我们描述了一种尽可能模拟体内情况的血液凝固反应体外模型。我们的模型表明,组织因子-因子VIIa复合物通过在携带组织因子的细胞环境中激活少量的因子IX和因子X来启动凝血。在初始反应中形成的因子Xa和因子IXa随后在凝血机制的后续相互作用中发挥非常不同的作用,导致血小板表面大量生成凝血酶。我们的结果还表明,在没有因子XII的情况下,因子XI可被凝血酶激活,并且因子XI的功能仅仅是增强因子IX向因子IXa的转化,从而导致血小板表面凝血酶生成增加。

相似文献

1
Newer concepts of blood coagulation.血液凝固的新观念。
Haemophilia. 1998 Jul;4(4):331-4. doi: 10.1046/j.1365-2516.1998.440331.x.
2
Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.凝血因子IXa和Xa在组织因子依赖性凝血起始过程中发挥不同作用。
Blood. 1995 Sep 1;86(5):1794-801.
3
Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.活性位点失活的凝血因子VIIa、Xa和IXa在组织因子启动的凝血细胞模型中抑制各个步骤。
Thromb Haemost. 1998 Oct;80(4):578-84.
4
Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.纤维蛋白凝块的形成:促凝血因子与抑制因子的平衡。
Clin Haematol. 1985 Jun;14(2):281-342.
5
Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.使用丝氨酸蛋白酶超灵敏检测法评估血液凝固的起始阶段。
J Biol Chem. 1997 Aug 22;272(34):21527-33. doi: 10.1074/jbc.272.34.21527.
6
Platelet procoagulant complex assembly in a tissue factor-initiated system.组织因子启动系统中血小板促凝复合物的组装
Br J Haematol. 1994 Oct;88(2):364-71. doi: 10.1111/j.1365-2141.1994.tb05032.x.
7
In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway.在人体中的体内实验证明,餐后富含甘油三酯的大脂蛋白通过内源性凝血途径激活凝血因子VII。
Arterioscler Thromb Vasc Biol. 1996 Nov;16(11):1333-9. doi: 10.1161/01.atv.16.11.1333.
8
The lipoprotein-associated coagulation inhibitor.脂蛋白相关凝血抑制剂。
Prog Hemost Thromb. 1991;10:243-68.
9
Activation of human factor VII during clotting in vitro.
Blood. 1985 Jan;65(1):218-26.
10
Transmission of a procoagulant signal from tissue factor-bearing cell to platelets.促凝血信号从携带组织因子的细胞向血小板的传递。
Blood Coagul Fibrinolysis. 1996 Jun;7(4):459-64. doi: 10.1097/00001721-199606000-00005.

引用本文的文献

1
Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives.基因治疗血友病的最新进展:展望前景。
Biomolecules. 2024 Jul 15;14(7):854. doi: 10.3390/biom14070854.
2
Targeting factor XI and factor XIa to prevent thrombosis.靶向因子 XI 和因子 XIa 以预防血栓形成。
Blood. 2024 Apr 11;143(15):1465-1475. doi: 10.1182/blood.2023020722.
3
Perioperative Management of Dental Surgery Patients Chronically Taking Antithrombotic Medications.慢性服用抗血栓药物的牙科手术患者的围手术期管理。
Int J Environ Res Public Health. 2022 Dec 2;19(23):16151. doi: 10.3390/ijerph192316151.
4
Updates on Novel Non-Replacement Drugs for Hemophilia.血友病新型非替代药物的最新进展。
Pharmaceuticals (Basel). 2022 Sep 23;15(10):1183. doi: 10.3390/ph15101183.
5
Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives.康西珠单抗作为A型或B型血友病患者的皮下预防治疗选择:证据综述与患者观点
J Blood Med. 2022 Apr 16;13:191-199. doi: 10.2147/JBM.S242219. eCollection 2022.
6
Characterization of Thrombin Generation Curve Shape in Presence of Platelets from Acute Venous Thromboembolism Patients.急性静脉血栓栓塞症患者血小板存在时凝血酶生成曲线形状的特征分析
J Clin Med. 2020 Sep 7;9(9):2892. doi: 10.3390/jcm9092892.
7
The influence of coagulation and inflammation research on the improvement of polytrauma care.凝血与炎症研究对多发伤救治改善的影响。
Eur J Trauma Emerg Surg. 2012 Jun;38(3):231-9. doi: 10.1007/s00068-011-0159-5. Epub 2011 Nov 9.
8
Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps.创伤止血与氧合研究关于远程损伤控制复苏的立场文件:定义、当前实践及知识空白
Shock. 2014 May;41 Suppl 1(0 1):3-12. doi: 10.1097/SHK.0000000000000140.
9
[Hemorrhaging during pregnancy].[孕期出血]
Anaesthesist. 2007 Oct;56(10):1075-89; quiz 1090. doi: 10.1007/s00101-007-1261-2.
10
Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies.通过计算得出的人类级联反应的脆弱点与当前的治疗策略一致。
PLoS Comput Biol. 2007 Jul;3(7):e142. doi: 10.1371/journal.pcbi.0030142.